Conclusion
Among the three included regions of Hungary, significant differences
were detected in the incidence of AMI, TIT of patients with STEMI and
their mortality rates. Additionally, logistic regression analysis
confirmed the independent prognostic significance of the region
regarding 30-day mortality; however, further research is necessary to
explore the data of smaller regional units with respect to infarction
treatment, with particular regard to accessing up-to-date care and
secondary prevention.
Acknowledgments: We would like to thank all participants of HUMIR and
Editage (www.editage.com) for English
language editing.
Conflict of Interest: none declared.
Data availability: The data from HUMIR that support the findings of this
study are available on reasonable request to the corresponding author.
References:
- Tuomilehto J, Kuulasmaa K. WHO Monica Project assessing CHD mortality
and morbidity. Int J Epidemiol 1989;18:S38-S45.
- Birkhead J, National Audit of Myocardial Infarction Project. Where are
we today? Early results from MINAP, the National Audit of Myocardial
Infarction Project. Heart 2003;89 Suppl 2:ii13-5; discussion
ii35-7.
- Jernberg T, Attebring MF, Hambraeus K, Ivert T, James S, Jeppsson A et
al The Swedish Web-system for enhancement and development of
evidence-based care in heart disease evaluated according to
recommended therapies (SWEDEHEART). Heart 2010;96:1617-1621.
- Sim DS, Jeong MH, Kang JC. Current management of acute myocardial
infarction: experience from the Korea Acute Myocardial Infarction
Registry. J Cardiol 2010;56:1-7.
- Wilkinson C, Weston C, Timmis A, Quinn T, Keys A, Gale CP. The
Myocardial Ischaemia National Audit Project (MINAP). Eur Heart J Qual
Care Clin Outcomes 2020;6:19-22.
- Blöndal M, Ainla T, Eha J, Loiveke P, Marandi T, Saar A et al
Comparison of management and outcomes of ST-segment elevation
myocardial infarction patients in Estonia, Hungary, Norway and Sweden
according to national ongoing registries. Eur Heart J 2020;41Suppl 2:1604.
- Edfors R, Jernberg T, Lewinter C, Blöndal M, Eha J, Lõiveke P et al
Differences in characteristics, treatments and outcomes in patients
with non-ST-elevation myocardial infarction -novel insights from four
national European continuous real-world registries. European Heart
Journal - Eur Heart J Qual Care Clin Outcomes 2021 Feb 19;qcab013.
doi: 10.1093/ehjqcco/qcab013. Online ahead of print.
- Tern PJW, Ho AKH, Sultana R, Ahn Y, Almahmeed W, Brieger D et al.
Comparative overview of ST-elevation myocardial infarction
epidemiology, demographics, management, and outcomes in five
Asia-Pacific countries: a meta-analysis. Eur Heart J Qual Care Clin
Outcomes 2021;7:6-17.
- Chung SC, Gedeborg R, Nicholas O, James S, Jeppsson A, Wolfe C et al
Acute myocardial infarction: a comparison of short-term survival in
national outcome registries in Sweden and the UK. Lancet
2014;383:1305-1312.
- Aktaa S, Gale CP. Regional differences in ST-segment elevation
myocardial infarction care and outcomes: a call for multi-national
cardiovascular registries. European Heart Journal - Quality of Care
and Clinical Outcomes 2020;7:1-2.
- Wallentin L, Gale CP, Maggioni A, Bardinet I, Casadei B. EuroHeart:
European Unified Registries On Heart Care Evaluation and Randomised
Trials. Eur Heart J 2019;40:2745-2749.
- Janosi A, Ferenci T, Ofner P, Lupkovics G, Becker D, Falukozy J et al
Does gender have prognostic value among patients with myocardial
infarction? Analysis of the data from the Hungarian Myocardial
Infarction Registry. J Womens Health (Larchmt)
2018;27:1491-1498.
- Bonow RO, Grant AO, Jacobs AK. The cardiovascular state of the union:
confronting healthcare disparities. Circulation
2005;111:1205-1207.
- Manrique-Garcia E, Sidorchuk A, Hallqvist J, Moradi T. Socioeconomic
position and incidence of acute myocardial infarction: a
meta-analysis. J Epidemiol Community Health 2011;65:301-309.
- Kampfer J, Yagensky A, Zdrojewski T, Windecker S, Meier B, Pavelko M
et al Long-term outcomes after acute myocardial infarction in
countries with different socio-economic environments: an international
prospective cohort study. BMJ Open 2017;7:e012715.
- Boncz I, Nagy J, Sebestyen A, Korosi L. Financing of health care
services in Hungary. Eur J Health Econ 2004;5:252-258.
- Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H
et al 2017 ESC Guidelines for the management of acute myocardial
infarction in patients presenting with ST-segment elevation: The Task
Force for the management of acute myocardial infarction in patients
presenting with ST-segment elevation of the European Society of
Cardiology (ESC). Eur Heart J 2018;39:119-177.
- Bellera CA, MacGrogan G, Debled M, de Lara CT, Brouste V,
Mathoulin-Pélissier S. Variables with time-varying effects and the Cox
model: Some statistical concepts illustrated with a prognostic factor
study in breast cancer. BMC MedRes Methodol 2010;10:20.
- Keys A, Karvonen MJ, Kimura N, Fidanza F, Taylor HL. Indexes of
relative weight and obesity. J Chron Dis 1972;25:329-343.
- Romo M, Koskenvuo M, Kaprio J, Langinvainio H, Pulkkinen P. Incidence
and prognosis of ischemic heart disease with respect to geographical
area. An epidemiological study of middle-aged Finns. Acta Med Scand
1982;212:355-360.
- Puska P, Mustaniemi H. Incidence and presentation of myocardial
infarction in North Karelia, Finland. Acta Med Scand
1975;197:211-216.
- Insam C, Paccaud F, Marques-Vidal P. The region makes the difference:
disparities in management of acute myocardial infarction within
Switzerland. Eur J Prev Cardiol 2014;21:541-548.
- Dondo TB, Hall M, Timmis AD, Yan AT, Batin PD, Oliver G, et al.
Geographic variation in the treatment of non-ST-segment myocardial
infarction in the English National Health Service: a cohort study. BMJ
Open 2016;6:e011600.
- Puymirat E, Battler A, Birkhead J, Bueno H, Clemmensen P, Cottin Y et
al Euro Heart Survey 2009 Snapshot: regional variations in
presentation and management of patients with AMI in 47 countries. Eur
Heart J Acute Cardiovasc Care 2013;2:359-370.
- Sokoloff A, Lefevre G, Teixeira N, Puymirat E, Beygui F, Vanzetto G et
al [Characteristics and management of ST-elevation myocardial
infarction in France: Regional variations in 2010]. Ann Cardiol
Angeiol (Paris). 2015;64:427-433.
- Bechtold D, Salvatierra GG, Bulley E, Cypro A, Daratha KB. Geographic
variation in treatment and outcomes among patients with AMI:
Investigating urban-rural differences among hospitalised patients. J
Rural Health 2017;33:158-166.
- De Luca G, Petrelli A, Landriscina T, Gnavi R, Giammaria M, Costa G.
Geographic and socio-economic differences in access to
revascularisation following acute myocardial infarction. Eur J Public
Health 2016;26:760-765.
- Odoi EW, Nagle N, Roberson S, Kintziger KW. Geographic disparities and
temporal changes in risk of death from myocardial infarction in
Florida, 2000-2014. BMC Public Health 2019;19:505.
- Kim RB, Kim HS, Kang DR, Choi JY, Choi NC, Hwang S et al The trend in
incidence and case-fatality of hospitalised acute myocardial
infarction patients in Korea, 2007 to 2016. J Korean Med Sci
2019;34:e322.
- Blais C, Hamel D, Rinfret S. Impact of socio-economic deprivation and
area of residence on access to coronary revascularisation and
mortality after a first acute myocardial infarction in Quebec. Can J
Cardiol 2012;28:169-177.
- Bucholz EM, Ma S, Normand SL, Krumholz HM. Race, socioeconomic status,
and life expectancy after acute myocardial infarction. Circulation
2015;132:1338-1346.
- Andrikopoulos G, Tzeis S, Terentes-Printzios D, Varounis C,
Vlachopoulos C, Mantas I et al Impact of income status on prognosis of
acute coronary syndrome patients during Greek financial crisis. Clin
Res Cardiol 2016;105:518-526.
- Patel N, Gupta A, Doshi R, Kalra R, Bajaj NS, Arora G et al
In-hospital management and outcomes after ST-segment-elevation
myocardial infarction in medicaid meneficiaries compared with
privately insured individuals. Circ Cardiovasc Qual Outcomes
2019;12:e004971.
- Shvartsur R, Shiyovich A, Gilutz H, Azab AN, Plakht Y. Short and
long-term prognosis following acute myocardial infarction according to
the country of origin. Soroka acute myocardial infarction II (SAMI II)
project. Int J Cardiol 2018;259:227-233.
- Reynolds K, Go AS, Leong TK, Boudreau DM, Cassidy-Bushrow AE, Fortmann
SP et al Trends in incidence of hospitalised acute myocardial
infarction in the Cardiovascular Research Network (CVRN). Am J Med
2017;130:317-327.
Title and table legends:
Table 1. Regional distributions of different type of myocardial
infarctions, medical history, and comorbidities
Legend: In the right column of the results table, the p-value of the
Chi-squared test is represented, i.e. whether the value of the examined
factors (e.g. the ratio of myocardial infarction) depends on the value
of another factor (e.g. in the present case, the region). We then added
the post-hoc test results after the p-value in brackets (regionally
differentiating between leftover tag values and p-values to show whether
the given region is significantly different in terms of frequency from
the whole).
Table 2. Patient delay, prehospital response time and types of
infarction per region
Table 3. 30-day and 1-year mortality of men and women in different types
of myocardial infarction treated with and without PCI, per region
Legend: The first p value belongs to the chi-squre test, while in
brackets the results of the post hoc tests are to be found
Title and figure legends:
Figure 1. The regions and their population data
Legend: WR: Western Region, CR: Central Region, ER: Eastern Region
Figure 2.a Time intervals of the emergency care process, NSTEMI
Legend: Arrival to location (T1), treatment on-site (T2) and time
interval between transferring the patient from the original location to
the hospital (T3)
Figure 2.b Time intervals of the emergency care process, STEMI
Legend: Arrival to location (T1), treatment on-site (T2) and time
interval between transferring the patient from the original location to
the hospital (T3)
Figure 3. Pharmacological treatment for secondary prevention recommended
upon hospital discharge per region.
Legend: WR: Western Region, CR: Central Region, ER: Eastern Region,
RAAS: renin–angiotensin–aldosterone system, PI: platelet inhibitors
Figure 4. Kaplan–Meier survival curves by regions, NSTEMI
Legend: Survival probabilities (lines and dots) and their confidence
intervals (vertical sections) are represented, per region
Figure 5. Kaplan–Meier survival curves by regions, STEMI
Legend: Survival probabilities (lines and dots) and their confidence
intervals (vertical sections) are represented, per region
Figure 6. Results of Cox Proportional Hazards Regression Model, NSTEMI
Legend: First column contains names of variables (the factors examined),
second column shows the mortality period, third and fourth column show
hazard ratio (HR) values in diagram and in tabulated formats (hazard
ratio denoted by with square and their confidence intervals denoted by
horizontal lines), fifth column shows the probability (P) values (a
variable was significant where P value was below 0.05, it is denoted by
0)
Figure 7. Results of Cox Proportional Hazards Regression Model, STEMI
Legend: First column contains names of variables (the factors examined),
second column shows the mortality period, third and fourth column show
hazard ratio (HR) values in diagram and in tabulated formats (hazard
ratio denoted by with square and their confidence intervals denoted by
horizontal lines), fifth column shows the probability (P) values (a
variable was significant where P value was below 0.05, it is denoted by
0)